News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
686,034 Results
Type
Article (39068)
Company Profile (279)
Press Release (646687)
Section
Business (203871)
Career Advice (1991)
Deals (35364)
Drug Delivery (86)
Drug Development (80809)
Employer Resources (168)
FDA (16090)
Job Trends (14806)
News (344564)
Policy (32440)
Tag
Academia (2530)
Alliances (49097)
Alzheimer's disease (1236)
Approvals (16025)
Artificial intelligence (134)
Bankruptcy (352)
Best Places to Work (11544)
Biotechnology (200)
Breast cancer (132)
Cancer (1126)
Cardiovascular disease (102)
Career advice (1660)
Cell therapy (238)
Clinical research (64303)
Collaboration (399)
Compensation (202)
COVID-19 (2532)
C-suite (97)
Data (1152)
Diabetes (154)
Diagnostics (6145)
Earnings (84839)
Employer resources (146)
Events (109653)
Executive appointments (320)
FDA (16646)
Funding (364)
Gene therapy (178)
GLP-1 (580)
Government (4327)
Healthcare (18681)
Infectious disease (2617)
Inflammatory bowel disease (106)
Interviews (308)
IPO (16306)
Job creations (3625)
Job search strategy (1417)
Layoffs (413)
Legal (7854)
Lung cancer (172)
Manufacturing (178)
Medical device (13179)
Medtech (13184)
Mergers & acquisitions (19147)
Metabolic disorders (407)
Neuroscience (1518)
NextGen Class of 2024 (6499)
Non-profit (4464)
Northern California (1514)
Obesity (234)
Opinion (179)
Patents (106)
People (56295)
Phase I (19970)
Phase II (28325)
Phase III (21119)
Pipeline (469)
Postmarket research (2554)
Preclinical (8501)
Radiopharmaceuticals (236)
Rare diseases (225)
Real estate (5890)
Regulatory (21544)
Research institute (2309)
Resumes & cover letters (349)
Southern California (1320)
Startups (3562)
United States (13782)
Vaccines (551)
Weight loss (169)
Date
Today (99)
Last 7 days (566)
Last 30 days (3673)
Last 365 days (35740)
2024 (33137)
2023 (40074)
2022 (51173)
2021 (55713)
2020 (54087)
2019 (46543)
2018 (35019)
2017 (32109)
2016 (31480)
2015 (37552)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29264)
2010 (27328)
Location
Africa (713)
Arizona (193)
Asia (37152)
Australia (6064)
California (3401)
Canada (1319)
China (259)
Colorado (150)
Connecticut (158)
Europe (79547)
Florida (474)
Georgia (121)
Illinois (347)
Indiana (198)
Kansas (96)
Maryland (586)
Massachusetts (2673)
Michigan (160)
Minnesota (276)
New Jersey (977)
New York (983)
North Carolina (712)
Northern California (1514)
Ohio (139)
Pennsylvania (859)
South America (1091)
Southern California (1320)
Texas (491)
Utah (91)
Washington State (368)
686,034 Results for "diasorin inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Deals
Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorin
DiaSorin (FTSE MIB: DIA) and Cytek Biosciences, Inc.(Nasdaq: CTKB) today announced that Luminex Corporation, a wholly owned subsidiary of DiaSorin, has signed an agreement with Cytek to sell substantially all of its assets related to the Flow Cytometry & Imaging (FCI) business unit.
February 13, 2023
·
9 min read
Deals
Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences Completed
DiaSorin (FTSE MIB: DIA) and Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that Luminex Corporation, a wholly owned subsidiary of DiaSorin, has completed the sale of substantially all of its assets related to the Flow Cytometry & Imaging (FCI) business unit to Cytek for approximately USD 46.5 million.
February 28, 2023
·
6 min read
Press Releases
ABS Bio, Inc. announces strategic investment by 3 Boomerang Capital
◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.
November 14, 2024
·
1 min read
Policy
QIAGEN and DiaSorin widen access to latent TB testing in the U.S. with FDA approval of QuantiFERON®-TB Gold Plus assay on LIAISON® XS
QIAGEN and DiaSorin announced that the U.S. Food and Drug Administration has approved the LIAISON® QuantiFERON®-TB Gold Plus assay for use on DiaSorin’s automated LIAISON® XS platform.
November 29, 2021
·
7 min read
Press Releases
Poseida Therapeutics, Inc. Announces Agreement to be Acquired by Roche Holdings, Inc.
November 26, 2024
·
9 min read
Drug Development
Our Mission at Voyager Therapeutics: Define the Future of Neurogenetic Medicines
We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system
May 8, 2024
·
2 min read
·
Voyager Therapeutics, Inc.
Press Releases
WW International, Inc. Announces CFO Transition
November 27, 2024
·
4 min read
Press Releases
Immunic, Inc. to Participate in Investor Conference in December
November 26, 2024
·
5 min read
Press Releases
Advantage Therapeutics Inc. Announces Formation of Klothea Bio, Inc. to Advance Research and Development of Klotho Protein for Age-Related Therapeutics
November 25, 2024
·
5 min read
Press Releases
Titan Pharmaceuticals, Inc. Announces Receipt of Notice from Nasdaq
November 28, 2024
·
3 min read
1 of 68,604
Next
